Methotrexate (Pre-conception only)

Study	Reference
Dawson, 2014	Dawson Maternal exposure to methotrexate and birth defects: a population-based study. Am J Med Genet A 2014; 164A:2212-6
Howren, 2020	Howren Perinatal exposure to conventional synthetic disease-modifying anti-rheumatic drugs in women with rheumatic disease and neonatal outcomes: a population-based study. Clin Exp Rheumatol ; 38:1080-1087
Matsui, 2003	Matsui Risk of abnormal pregnancy completing chemotherapy for gestational trophoblastic tumor. Gynecol Oncol 2003; 88:104-7
Svirsky, 2017	Svirsky Outcomes of conception subsequent to methotrexate treatment for an unruptured ectopic pregnancy. Int J Gynaecol Obstet 2017; 139:170-173 Svirsky The safety of conception occurring shortly after methotrexate treatment of an ectopic pregnancy. Reprod Toxicol 2009; 27:85-7
Svirsky, 2009	Svirsky The safety of conception occurring shortly after methotrexate treatment of an ectopic pregnancy. Reprod Toxicol 2009; 27:85-7
Weber-Schoendorfer (Controls exposed to other treatment, sick), 2014	Weber-Schoendorfer Pregnancy outcome after methotrexate treatment for rheumatic disease prior to or during early pregnancy: a prospective multicenter cohort study. Arthritis Rheumatol 2014; 66:1101-10
Weber-Schoendorfer (Controls unexposed, disease free), 2014	Weber-Schoendorfer Pregnancy outcome after methotrexate treatment for rheumatic disease prior to or during early pregnancy: a prospective multicenter cohort study. Arthritis Rheumatol 2014; 66:1101-10